859027-01-3

Basic information

• Product Name: Benzoic acid, 4-(bromomethyl)-3-(trifluoromethyl)-, ethyl ester
• Synonyms: ethyl 4-(bromomethyl)-3-trifluoromethylbenzoate;4-bromomethyl-(3-trifluoromethyl)benzoic acid ethyl ester;ethyl 4-bromomethyl-3-trifluoromethylbenzoate;4-Bromomethyl-3-trifluoromethyl-benzoic acid ethyl ester;ethyl 4-(bromomethyl)-3-(trifluoromethyl)benzoate
• CAS NO: 859027-01-3
• Molecular Formula: C11H10BrF3O2
• Molecular Weight: 311.098
• Mol File: 859027-01-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(bromomethyl)-3-(trifluoromethyl)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(bromomethyl)-3-(trifluoromethyl)-, ethyl ester(859027-01-3)
• EPA Substance Registry System: Benzoic acid, 4-(bromomethyl)-3-(trifluoromethyl)-, ethyl ester(859027-01-3)

Safety Data

• Hazardous Substances Data: 859027-01-3(Hazardous Substances Data)

Upstream product

• 859213-39-1 4-(bromomethyl)-3-(trifluoromethyl)benzoic acid 
• 64-17-5 ethanol 
• 261952-01-6 4-methyl-3-(trifluoromethyl)benzoic acid 
• 859026-99-6 4-methyl-3-trifluoromethyl-benzoic acid ethyl ester 

Downstream Products

• 859213-21-1 ethyl 4-[(S)-3-(t-butoxycarbonylamino)-2-oxopyrrolidin-1-ylmethyl]-3-trifluoromethylbenzoate 
• 1253186-65-0 ethyl4-[(3-{[(2,6-difluorophenyl)carbonyl]amino}-1H-pyrazol-1-yl)methyl]-3-(trifluoromethyl)benzoate 
• 859212-83-2 ethyl 4-(dimethoxyphosphorylmethyl)-3-trifluoromethylbenzoate 
• 859027-02-4 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl) benzoic acid 
• 859027-00-2 4-(4-methyl-piperazin-1-ylmethyl)-3-trifluoromethyl-benzoic acid ethyl ester 

Relevant articles and documents

BENZAMIDE DERIVATIVE

The present invention relates to benzamide derivatives represented by formula (I) or pharmaceutically acceptable salts thereof.

THIENO (2, 3B) PYRAZINE COMPOUNDS AS B - RAF INHIBITORS

The invention relates to compounds according to general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of cancer.

N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS

The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.